Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02691221 · ClinicalTrials.gov registry record · NA
ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients
A NA study of Suicide, Suicidal Ideation, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT02691221 is a NA study of Suicide, Suicidal Ideation that has completed, run by Emory University. The registered enrollment target is 13 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02691221, a NA study of Suicide, Suicidal Ideation, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to increase use and availability, as well as assess the feasibility of the ReliefLink (RL) application for use in conjunction with standard care to promote psychological health and prevent suicidal behavior.
Conditions Studied
Interventions
- BEHAVIORAL Relief Link Application Daily Tasks
Study Locations (1)
Georgia
- Grady Health System - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02691221
The ClinicalTrials.gov registry entry for NCT02691221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suicide, Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Relief Link Application Daily Tasks is the first listed.
NCT02691221 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02691221 about?
NCT02691221 is a clinical study titled "ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients". The purpose of this study is to increase use and availability, as well as assess the feasibility of the ReliefLink (RL) application for use in conjunction with standard care to promote psychological health and prevent suicidal behavior.
What is the current status of trial NCT02691221?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-04. Estimated completion is 2017-10.
What conditions does trial NCT02691221 study?
This clinical trial studies the following conditions: Suicide, Suicidal Ideation.
What interventions are being tested in trial NCT02691221?
The interventions under investigation include: Relief Link Application Daily Tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT02691221?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02691221 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.